Monitoring the birth of an industry
By Gregg A. Masters, MPH Whether you love em (anyone love their health insurance company?) or hate em, major health plans are in a reasonable position to lead if not steward the needed healthcare transformation. While physicians aka ‘disorganized medicine’ too often circle the wagons and shoot in, and whereas hospital systems present too much …
Continue reading “Strategic Market Tea Leaves: The Health Plan Perspective”
By Gregg A. Masters, MPH The 31st annual get together of biotech, pharma and an eclectic litany of publically held healthcare company and many impressive tax exempt health system peeps was my first albeit from a somewhat disadvantaged, i.e., ‘crasher’, status. Yet, in the overall program mix there seemed to be something for everybody from …
Continue reading “JP Morgan Healthcare Conference Unbundled: Something for Everyone?”
By Gregg A. Masters, MPH Industry watchers have to be impressed by the announcement from CMS today that effectively doubles the ACO count from prior reported totals. Is it just me, or can you can sense the subtle shift in market sentiment from skepticism to loss of first mover opportunity in one’s market. For the list of …
Continue reading “And the Circle Grows! CMS Announces Another Round of ACOs”
By Gregg A. Masters, MPH We’re here in the ‘city by the bay’ for the 31st annual assembly of biotech and pharma peeps and the money they seek from the venture capital world. Not exactly my tribe, but my interest was sparked by the generous ‘non profit track’ with many nameplate integrated delivery systems in …
November 27th, 2012 [Editor’s note: portions of broadcast present with low audio]. NEHI Summit Explores Innovations In the Emerging ACO Landscape The opportunities – and the challenges – presented by the rapid movement towards Accountable Care Organizations were the subject of a recent NEHI summit that drew perspectives from across health care: “I think ACOs …
Continue reading “New England Healthcare Institute (NEHI) ACO Innovation Summit”
By Gregg A. Masters, MPH From Leavitt Partners. a webinar held on November 8th, 2012. The focus is on ACOs, and represents an update post elections from their previous reporting here.
By Gregg A. Masters, MPH Last Friday I moderated the HealthIT social media focused tweetchat tagged ‘#HITsm’, see context piece here, and transcript here. The theme centered on the value or centrality of HealthIT to ACO success. The conversation was lively (for additional context, ACO surprise provides metrics on dispersion and penetration into Medicare and commercial markets), and …
Continue reading “A/C/O: ‘Another Compromised Organization’ or ‘A Coordinated Orchestra?’”
By Gregg A. Masters, MPH Ah yes, those ‘white waters’ of health reform or more aptly put ‘transformation’ (you know, the triple aim thingy). As more has been revealed, I offer a quasi ‘mea culpa’ of sorts… Light years ago, or so it seems, as I began at least the blogging portion of my social …
Continue reading “None of the Ransomed Ever Knew How Deep Were the Waters Crossed”
By Vince Kuraitis, JD, MBA A recent analysis of the ACO market by Oliver Wyman market suggests we’re well on our way toward being “there”. My personal take on this report: Provocative, fresh, thoughtful, well reasoned, expansive — albeit a bit of a stretch. However, I suspect many others will describe it as: Speculative, harebrained, unsupported, overly …
Continue reading “ACOs: Here, There, Everywhere? Or Are We Quibbling at the Edges?”
By Gregg A. Masters, MPH As originally posted at JustOncology. The best business model for oncology care is not yet obvious to me. But it is crystal clear that innovative new models are being hatched before our eyes.. via Oncology Times Since CMS (via HHS) issued the final rule addressing ACO provisions and specifically ‘excluded’ oncologists …
Continue reading “ACOs, Oncology and the Future of Better Cancer Care”
acowatch.me 